You are here

Study Evaluating rFIX; BeneFIX® in Hemophilia B

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Los Angeles, California, 90027 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hemophilia B
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
12 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Hemophilia B (FIX:C less than 2%)

- Previous treatment of at least 150 exposure days using any FIX product

- 12 years of age and older

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- The patient has a currently detectable factor IX inhibitor or a history of inhibitors.
(A family history of inhibitors will not exclude the patient)

- Known hypersensitivity to protein pharmaceuticals or agents related to the test
article, e.g. hamster proteins

- Patient has a genetic coagulation disorder other than hemophilia B

NCT00093171
Pfizer
Completed
Study Evaluating rFIX; BeneFIX® in Hemophilia B

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now